Cargando…
Optimizing use of 5-ASA in the treatment of ulcerative colitis: Focus on patient compliance and adherence
Ulcerative colitis is a chronic condition that requires long-term treatment. The first-line therapy remains 5-ASA, which is available in a variety of different formulations and dosing schedules. Multiple studies have demonstrated that adherence rates to prescribed 5-ASA products is below what would...
Autores principales: | Bernick, Steven J, Kane, Sunanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417898/ https://www.ncbi.nlm.nih.gov/pubmed/22915953 |
Ejemplares similares
-
The Challenge of Compliance and Persistence: Focus on Ulcerative Colitis
por: Kane, Sunanda V., et al.
Publicado: (2008) -
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
por: Louis, Edouard, et al.
Publicado: (2022) -
Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis
por: Mitra, Debanjali, et al.
Publicado: (2012) -
Current approaches to the management of new-onset ulcerative colitis
por: Marchioni Beery, Renée, et al.
Publicado: (2014) -
Adherence in ulcerative colitis: an overview
por: Testa, Anna, et al.
Publicado: (2017)